Clinical Trials Directory

Trials / Recruiting

RecruitingNCT07143890

Iron Absorption From Plant Heme Iron

Iron Absorption From Plant-Derived Heme Iron: An Experimental Study in Iron-Deficient Women (PHIA)

Status
Recruiting
Phase
N/A
Study type
Interventional
Enrollment
45 (estimated)
Sponsor
ETH Zurich · Academic / Other
Sex
Female
Age
18 Years – 45 Years
Healthy volunteers
Accepted

Summary

Heme, an iron protoporphyin IX complex, consists of a ferrous ion captured in a porphyrin ring acting as a tetradentate ligand. The unique features of heme iron -its unusually high absorption in foods and its resistance to luminal inhibitors of iron absorption- make it a potentially interesting iron fortificant. This study aims to compare fractional iron absorption from two plant-derived heme iron compounds-iron chlorophyllin and soy hemoglobin-with ferrous sulfate (negative control) and porcine hemoglobin (positive control) in iron-deficient women. All four compounds will be intrinsically labeled with stable iron isotopes. Fractional absorption will be assessed 14 days after test meal administration via erythrocyte iron incorporation. Absorption will be tested in two matrices: water and maize porridge (an inhibitory matrix). Each participant will consume all test conditions in a randomized order, allowing for within-subject comparisons.

Conditions

Interventions

TypeNameDescription
OTHERIron chlorophyllin + no-matrixWater with labelled Fe chlorophyllin (54Fe)
OTHERSoyHb + no-matrixWater with labelled soy hemoglobin (58Fe)
OTHERFeSO4 + no-matrixWater with labelled ferrous sulfate (58Fe)
OTHERHb + no-matrixWater with labelled porcine hemoglobin (57Fe)
OTHERIron chlorophyllin + meal-matrixMaize porridge with labelled Fe chlorophyllin (54Fe)
OTHERSoyHb + meal-matrixMaize porridge with labelled soy hemoglobin (58Fe)
OTHERFeSO4 + meal-matrixMaize porridge with labelled ferrous sulfate (57Fe)
OTHERHb + meal-matrixMaize porridge with labelled porcine hemoglobin (57Fe)

Timeline

Start date
2025-09-22
Primary completion
2026-05-01
Completion
2026-05-01
First posted
2025-08-27
Last updated
2026-02-12

Locations

1 site across 1 country: Switzerland

Source: ClinicalTrials.gov record NCT07143890. Inclusion in this directory is not an endorsement.